Authors: Podzamczer, D Mallolas, J Pena, JM Pulido, F Aguirrebengoa, K Barros, C Blazquez, R Costa, JR Dronda, F Ena, J Guerrero, A Gutierrez, F Juega, J Labarga, P Locutura, J Aldeguer, JL Moreno, S Noguerado, A Ocana, I Padilla, B Perez-Cecilia, E Elias, MJP Portilla, J Rivero, A Roca, V

Citation: D. Podzamczer et al., Treatment of opportunistic infections among adult and adolescent patients infected with the human immunodeficiency virus in the era of highly active anti-retroviral therapy, ENFERM INF, 19(8), 2001, pp. 376-392

Authors: Ribera, E Pou, L Fernandez-Sola, A Campos, F Lopez, RM Ocana, I Ruiz, I Pahissa, A

Citation: E. Ribera et al., Rifampin reduces concentrations of trimethoprim and sulfamethoxazole in serum in human immunodeficiency virus-infected patients, ANTIM AG CH, 45(11), 2001, pp. 3238-3241

Authors: Ribera, E Fernandez-Sola, A Juste, C Rovira, A Romero, FJ Armadans-Gil, L Ruiz, I Ocana, I Pahissa, A

Citation: E. Ribera et al., Comparison of high and low doses of trimethoprim-sulfamethoxazole for primary prevention of toxoplasmic encephalitis in human immunodeficiency virus-infected patients, CLIN INF D, 29(6), 1999, pp. 1461-1466